Deanne Tibbitts, PhD

Assistant Professor
Email

Dr. Deanne Tibbitts is currently an Assistant Professor in the School of Graduate Studies and a Research Investigator at the Helfgott Research Institute. A Georgia native, Dr. Tibbitts completed her bachelor’s degree in Genetics and Cellular Biology at the University of Georgia before moving to Portland to pursue her doctoral work. Dr. Tibbitts completed her PhD in Molecular and Medical Genetics at Oregon Health and Science University, where she studied the molecular basis of leukemia and the application of targeted cancer therapeutics.

Dr. Tibbitts joined NUNM as full-time faculty in 2014, teaching in both the Nutrition and Integrative Medicine Research programs and serving as thesis advisor to students pursuing research in integrative oncology. Dr. Tibbitts is currently completing a clinical research fellowship in complementary and integrative health through the NCCIH-funded BRIDG T90/R90 program, a collaboration between NUNM and the University of Washington. Her research focuses on mind-body approaches to improving psychosocial outcomes, symptom management, and quality of life in cancer survivors.

Curriculum Vitae


Publications

Withee ED, Tippens KM, Dehen R, Tibbitts D, Hanes D, Zwickey H. 2017. Effects of Methylsulfonylmethane (MSM) on Exercise-Induced Oxidative Stress, Muscle Damage, and Pain Following a Half-Marathon: a Double-Blind, Randomized, Placebo-Controlled Trial. Journal of the International Society of Sports Nutrition 14:24.

Richard NP, Pippa R, Cleary MM, Puri A, Tibbitts D, Mahmood S, Christensen DJ, Jeng S, McWeeney S, Look AT, Chang BH, Tyner JW, Vitek MP, Odero MD, Sears R, Agarwal A. 2016. Combined targeting of SET and tyrosine kinases provides an effective therapeutic approach in human T-cell acute lymphoblastic leukemia. Oncotarget 7(51):84214-84227.

Vasilevsky N, Schafer M, Tibbitts D, Wright K, Zwickey H. 2015. Curriculum Development of a Research Laboratory Methodology Course for Complementary and Integrative Medicine Students. Medical Science Educator 25(2):171-5.

Tibbitts DC, Escamilla-Powers JR, Zhang X, Sears RC. 2012. Studying c-Myc serine 62 phosphorylation in leukemia cells: concern over antibody cross- reactivity. Blood 119(22):5334-5.

Arnold HK, Zhang X, Daniel CJ, Tibbitts D, Escamilla-Powers J, Farrell A, Tokarz S, Morgan C, Sears RC. 2009. The Axin1 scaffold protein promotes formation of a degradation complex for c-Myc. EMBO Journal 28(5):500-12.

O’neil J, Grim J, Strack P, Rao S, Tibbitts D, Winter C, Hardwick J, Welcker M, Meijerink JP, Pieters R, Draetta G, Sears R, Clurman BE, Look AT. 2007. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to {gamma}-secretase inhibitors. Journal of Experimental Medicine 204(8):1813-24.

Malempati S, Tibbitts D, Cunningham M, Akkari Y, Olson S, Fan G, Sears RC. 2006. Aberrant stabilization of c-Myc protein in some lymphoblastic leukemias. Leukemia 20(9):1572-81.

Tibbitts D, Rao RR, Shin S, West FD, Stice SL. 2006. Uniform adherent neural progenitor populations from rhesus embryonic stem cells. Stem Cells and Development 15(2):200-8.Vasilevsky N, Schafer M,